Latest Operational Outlook News

Duxton Farms has completed its strategic merger, acquiring full ownership of four Australian agricultural companies and setting the stage for a diversified investment platform.

Tlou Energy Limited reported a $1.07 million net cash outflow for Q3 2025 and secured $2.37 million through equity issuance, yet its funding runway remains just one quarter. The company is actively pursuing additional capital to sustain operations amid ongoing expenditure.

Bioxyne Limited has reported a record quarterly revenue of A$14.1 million for Q1 FY26, driven by strong demand in Europe and Australia, alongside a strategic dual listing on the Frankfurt Stock Exchange.

Ampol Limited reported a robust third quarter in 2025 with refinery margins hitting a notable high, offsetting volume declines and setting the stage for strategic growth.

Corazon Mining reported a challenging cash flow quarter ending September 2025, with net outflows in operating and investing activities, but secured a $2 million capital raise to support ongoing exploration.

Ark Mines Ltd reported a significant cash burn in the September quarter, prompting a $500,000 capital raise and plans to secure $4 million from a royalty sale to sustain operations.

Power Minerals Limited has advanced its critical minerals portfolio with the acquisition of the Gamma Heavy Rare Earths and Uranium Project in California and completed the Santa Anna Niobium-REE-Gallium Project acquisition in Brazil, supported by a combined $6.7 million capital raise.

Dreadnought Resources has upgraded its scoping study for the Star of Mangaroon gold project, increasing the initial production target by 24% to approximately 24,700 ounces at 8.3 g/t gold, while halving the maximum cash drawdown to $5.4 million.

Tyranna Resources has advanced its exploration and acquisition efforts in Angola, securing a major stake in the Chinguar Gold Project and extending its lithium-caesium project tenure, supported by a solid cash position.

Dimerix Limited reports solid progress in its Phase 3 trial for DMX-200 targeting rare kidney disease FSGS, backed by orphan drug status in Japan and a robust cash position. The company prepares to engage the FDA on new data supporting regulatory approval.

Macro Metals Limited has bolstered its financial position with a $2 million capital raise while making significant progress across its iron ore and construction sand projects, underpinned by strong Indigenous joint ventures and mining services development.

Assetora Limited disclosed a $341,000 net operating cash outflow for the September 2025 quarter, supported by $1.6 million in total available funding including cash reserves and financing facilities.